Drugs.com Medication Guide is a well-regarded medical app that is free with in-app purchases. With a 4.8/5 rating from 50.1K reviews, it maintains solid user satisfaction. Users particularly appreciate medication management & information, though monetization & pricing remains a common concern.

What Is Drugs.com Medication Guide?

Drugs.com Medication Guide is a leading medical reference app providing peer-reviewed data on 24,000+ medications for 25 million monthly U.S. visitors. It bridges the gap between professional clinical data and consumer utility through its Pill Identifier and Price Guide. While it maintains high ratings, it is currently navigating a risky transition toward a more aggressive subscription-based monetization model.

Current Momentum

v3.1.51 Β· 4w ago

Maintenance

Drugs.com Medication Guide is currently in maintenance mode, focusing on incremental refinements to printing and UI animations. No major feature updates have been released in the last four months.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Active Nemesis

epocrates: Drug Info & Pill ID

epocrates: Drug Info & Pill ID

By Epocrates

Other Rivals

Medscape
GoodRx: Prescription Savings
SingleCare Rx Pharmacy Coupons
Mayo Clinic
PillEye – tablet, pill counter

7-Day Rank Pulse πŸ‡ΊπŸ‡Έ

No ranking data

Main Category

MedicalGrossing
AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Recent User Mood πŸ‡ΊπŸ‡Έ

Excited
Excited
Medication Management & Information
Monetization & Pricing

What makes this app unique?

What Does It Look Like?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Pill IdentifierDifferentiator

Searchable database of over 14,000 medications by imprint, color, and shape.

Price GuideDifferentiator

Locates lowest medication prices and nearby pharmacies to assist with cost management.

Professional ToolsDifferentiator

Access to FDA monographs and clinical data tailored for healthcare professionals.

My Med ListStandard

Personalized health profile to track medications and interactions with offline access.

Who is it for & how much does it cost?

Target Audience

Patients, caregivers, and healthcare professionals seeking reliable, peer-reviewed medication information and management tools.

Pricing

Freemium
  • Free: Core medication info with ads
  • Plus Plan ($8.99/mo): Ad-removal and unlimited accounts

The app is shifting from a primarily ad-supported model to a high-priced subscription ($8.99/mo), which has triggered a sharp decline in user sentiment and 'greedy' brand associations.

Who Built It?

Enrichment in progress

Publisher profile available very soon

What other apps does Drugs.com make?

What do users think recently?

High confidence Β· 50.1K reviews analyzed

What is the recent mood?

Excited
Excited

β€œRecent user voice shows a excited sentiment. Users appreciate medication management & information and pill identification, but report monetization & pricing and technical issues & access.”

What Users Love

Medication Management & Information

Awesome way to keep track of medication and possible side effects

Explane all things about drug specially drug-drug interactions

Pill Identification

I put the number on the pill in and it tells me what it is.

very useful and not only looking up drugs, pill identifier

What Frustrates Users

Monetization & Pricing

now they got greedy and it erased all of my meds and they want money

Now when I go to renew, I only see an $8.99 PER MONTH option

Technical Issues & Access

Unable to access even to sign in

why is it showing twice after the last update?

What is the competitive landscape for Drugs.com Medication Guide?

How's The Medical Market?

Market outlook for this category

Available very soon

Medical Market Trend

Medical market trend & dynamics

Available very soon

The rivals identified

The Nemesis

Head to Head

While Drugs.com leads in consumer accessibility and price transparency, Epocrates maintains the edge in professional trust and clinical utility. Drugs.com faces a challenge with its declining sentiment trend compared to the stable professional reception of Epocrates.

What sets Drugs.com Medication Guide apart

  • +

    Stronger focus on consumer-facing price comparison and pharmacy discount tools

  • +

    More accessible language for patients and non-professional caregivers

What's epocrates: Drug Info & Pill ID's Edge

  • -

    Higher overall rating volume and established professional authority

  • -

    More frequent updates to clinical guidelines and drug monographs

Contenders

Medscape

Medscape

β˜…3.6 (1K)

WebMD

A massive medical reference platform that includes a robust drug database and interaction checker used by millions of professionals.

-

Includes a broader range of medical news, disease reference, and CME credits

-

Completely free access to a massive database of clinical information

GoodRx: Prescription Savings

GoodRx: Prescription Savings

GoodRx

The primary competitor for the 'Price Guide' feature, GoodRx is the industry leader in medication discounts and price transparency.

-

Superior pharmacy network and deeper discounts on prescriptions

-

Integrated telehealth services and mail-order pharmacy options

Peers

SingleCare Rx Pharmacy Coupons

SingleCare Rx Pharmacy Coupons

SingleCare

Competes directly with the medication savings and pharmacy locator features of Drugs.com.

-

Focuses exclusively on the financial aspect of medication management

-

Offers a loyalty program for additional savings on refills

Mayo Clinic

Mayo Clinic

β˜…3.4 (3K)

Mayo Clinic

A high-authority health information app that users often use to cross-reference drug side effects and treatments.

-

Content authored by world-renowned medical experts

-

Focuses on the patient-provider relationship and appointment management

New Kids on the Block

PillEye – tablet, pill counter

PillEye – tablet, pill counter

Medility Inc.

A specialized tool using computer vision to count and identify pills, representing a more tech-forward approach to pill management.

-

Uses AI-powered camera scanning for instant pill counting

-

Highly focused utility that solves a specific pain point for patients with complex regimens

The outtake for Drugs.com Medication Guide

SWOT Analysis

Core Strengths

  • Massive database of 24,000+ peer-reviewed medications
  • Highly-rated visual Pill Identifier tool
  • Strong consumer brand trust (25M monthly visitors)
  • Integrated pharmacy discount/pricing tools

Critical Frictions

  • Aggressive $8.99/mo subscription pricing causing user friction
  • Technical bugs in v3.1.51 (login failures, UI duplication)
  • Manual entry for pill ID vs emerging AI camera scanning

Growth Levers

  • Implement AI image search for pill identification to match PillEye
  • Develop robust offline mode for users in low-connectivity areas
  • Introduce tiered pricing to mitigate 'all-or-nothing' subscription backlash

Market Threats

  • Epocrates' dominance in professional clinical trust
  • Medscape's free access to clinical data attracting professional users
  • GoodRx's superior pharmacy network and brand recognition

What are the next best moves?

high

Re-evaluate 'Plus Plan' pricing and feature gating.

High-frequency complaints indicate users feel 'erased' and priced out by the $8.99/mo tier, posing a major churn risk.

high

Hotfix login and UI duplication bugs in v3.1.51.

Medium-frequency complaints specifically cite inability to sign in and medications showing twice after the latest update.

medium

Roadmap AI-powered camera scanning for Pill Identification.

User feedback explicitly requested an AI image search tool, and competitor PillEye is already utilizing computer vision for this purpose.

Feature Gaps vs Competitors

  • AI-powered camera scanning (available in PillEye)
  • Medical calculators and risk assessment tools (available in Epocrates)
  • Telehealth services and mail-order options (available in GoodRx)
  • CME credits for professionals (available in Medscape)

Key Takeaways

Drugs.com is a consumer powerhouse currently jeopardizing its user loyalty through an aggressive and poorly received monetization pivot. While its core utility in pill identification and interaction checking remains a major strength, the PM must urgently address the $8.99/mo price friction and technical stability issues to prevent a mass exodus to free alternatives like Medscape.

Where Is It Heading?

Declining

Frustrated user base regarding the $8.99/mo subscription shift β€” high risk of churn to free competitors.

Technical regressions in v3.1.51 (Mar 2026) causing login failures and UI bugs.

Active feature investment in UI customization and dark mode (Mar 2026) shows the app is not in maintenance mode.

Independent intel to help builders create better apps.

No publisher influence. No third-party bias. Built with objectivity in mind to serve the builder community.

Hope this helps & keep building! Β· Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. β€œDrugs.com Medication Guide Intelligence Report.” Updated Apr 12, 2026. https://marlvel.ai/intel-report/medical/drugs-com-medication-guide

Agent Markdown (.md)Β·

Data licensed under CC-BY-NC 4.0